Market Rebellion TV
← Back to News

Various

Analyst Upgrades and Downgrades For the Week of November 11th

Analyst upgrades, downgrades, and more

By Justin Nugent · November 11, 2024
Analyst Upgrades and Downgrades For the Week of November 11th

November 14th

Upgrades:

  1. American Airlines (AAL) – Barclays upgraded from Underweight to Equal Weight, price target raised from $10 to $16.
  2. BXP, Inc. (BXP) – Compass Point upgraded from Neutral to Buy, price target raised from $80 to $88.
  3. Campbell Soup (CPB) – Piper Sandler upgraded from Neutral to Overweight, price target raised from $47 to $56.
  4. Douglas Emmett (DEI) – Scotiabank upgraded from Sector Perform to Sector Outperform, price target raised from $16 to $21.
  5. Doximity (DOCS) – Morgan Stanley upgraded from Underweight to Equal-Weight, price target raised from $33 to $53.
  6. Inseego (INSG) – ROTH MKM upgraded from Neutral to Buy, price target raised from $13 to $15.
  7. ArcelorMittal (MT) – BofA Securities upgraded from Neutral to Buy, price target raised from $30 to $32.9.
  8. Prudential (PRU) – Evercore ISI upgraded from Underperform to In-line, price target raised from $117 to $140.
  9. Suncor Energy (SU) – Desjardins upgraded from Hold to Buy.
  10. Unum Group (UNM) – Evercore ISI upgraded from In-line to Outperform, price target raised from $67 to $84.
  11. Spire Global (SPIR) – Craig Hallum upgraded from Hold to Buy, price target raised from $8 to $20.

Downgrades:

  1. Atlas Energy Solutions (AESI) – Citigroup downgraded from Buy to Neutral, price target lowered from $23 to $22.
  2. Blink Charging (BLNK) – UBS downgraded from Buy to Neutral, price target lowered from $3 to $2.
  3. Boxlight (BOXL) – Alliance Global Partners downgraded from Buy to Neutral.
  4. ESS Inc. (GWH) – Oppenheimer downgraded from Outperform to Perform.
  5. ESS Inc. (GWH) – Robert W. Baird downgraded from Neutral to Underperform, price target lowered from $14 to $9.
  6. Ibotta (IBTA) – UBS downgraded from Buy to Neutral, price target lowered from $90 to $65.
  7. Innoviz Technologies (INVZ) – Cantor Fitzgerald downgraded from Overweight to Neutral.
  8. Jack In The Box (JACK) – Northcoast downgraded from Buy to Neutral.
  9. Jackson Financial (JXN) – Evercore ISI downgraded from In-line to Underperform, price target raised from $74 to $95.
  10. Kilroy Realty (KRC) – Scotiabank downgraded from Sector Perform to Sector Underperform.
  11. Kronos (KRON) – TD Cowen downgraded from Buy to Hold.
  12. Kronos (KRON) – Piper Sandler downgraded from Overweight to Neutral, price target lowered from $6 to $1.
  13. Liberty Broadband (LBRDA) – Rosenblatt downgraded from Buy to Neutral, price target raised from $91 to $92.
  14. Realty Income (O) – Mizuho downgraded from Outperform to Neutral, price target lowered from $64 to $60.
  15. Plug Power (PLUG) – BTIG Research downgraded from Buy to Neutral.
  16. Papa John’s (PZZA) – KeyBanc Capital Markets downgraded from Overweight to Sector Weight.
  17. Sun Communities (SUI) – UBS downgraded from Buy to Neutral, price target lowered from $155 to $134.
  18. TelevisaUnivision (TV) – JP Morgan downgraded from Overweight to Neutral.
  19. Zeta Global (ZETA) – KeyBanc Capital Markets downgraded from Overweight to Sector Weight.
  20. Digi Intl (DGII) – Craig Hallum downgraded from Buy to Hold, price target lowered from $28 to $32.
  21. Global Ship Lease (GSL) – Clarksons Platou downgraded from Buy to Neutral.
  22. Wag! Group (PET) – Craig Hallum downgraded from Buy to Hold.
  23. Allurion Technologies (ALUR) – Chardan Capital Markets downgraded from Buy to Neutral.
  24. Nu Holdings (NU) – Itau BBA downgraded from Outperform to Market Perform.
  25. NICE (NICE) – Piper Sandler downgraded from Overweight to Neutral.
  26. Hims & Hers Health (HIMS) – BofA Securities downgraded from Buy to Underperform.

New Coverage Initiated:

  1. Achieve Life Sciences (ACHV) – Rodman & Renshaw initiated with a Buy and a price target of $12.
  2. Adial Pharmaceuticals (ADIL) – Rodman & Renshaw initiated with a Buy and a price target of $8.
  3. Amgen (AMGN) – Citigroup initiated with a Neutral and a price target of $335.
  4. Biogen (BIIB) – Citigroup initiated with a Neutral and a price target of $190.
  5. Broadstone Net Lease (BNL) – UBS initiated with a Neutral and a price target of $18.
  6. Blueprint Medicines (BPMC) – JP Morgan initiated with an Overweight and a price target of $126.
  7. Cogent Communications (CCOI) – UBS initiated with a Buy and a price target of $102.
  8. Carlisle Cos (CSL) – Truist initiated with a Hold and a price target of $460.
  9. EPR Properties (EPR) – UBS initiated with a Neutral and a price target of $48.
  10. Eupraxia Pharmaceuticals (EPRX) – Rodman & Renshaw initiated with a Buy and a price target of $9.
  11. Four Corners Property Trust (FCPT) – UBS initiated with a Buy and a price target of $33.
  12. Fabrinet (FN) – Barclays initiated with an Equal Weight and a price target of $292.
  13. Gilead Sciences (GILD) – Citigroup initiated with a Buy and a price target of $125.
  14. Maravai Life Sciences (MRVI) – Wolfe Research initiated with a Peer Perform rating.
  15. Vail Resorts (MTN) – UBS initiated with a Neutral and a price target of $185.
  16. Omeros (OMER) – Rodman & Renshaw initiated with a Buy and a price target of $9.
  17. Regeneron Pharma (REGN) – Citigroup initiated with a Neutral and a price target of $895.
  18. Repligen (RGEN) – Wolfe Research initiated with a Peer Perform rating.
  19. Rockwell Medical (RMTI) – Rodman & Renshaw initiated with a Buy and a price target of $5.
  20. Turning Point Brands (TPB) – Oppenheimer initiated with an Outperform and a price target of $65.
  21. Vertex Pharma (VRTX) – Citigroup initiated with a Buy and a price target of $575.
  22. PROCEPT BioRobotics (PRCT) – Jefferies initiated with a Hold and a price target of $95.

November 13th

Upgrades:

  1. BASF AG (BASFY) – Jefferies: Hold → Buy
  2. BankUnited (BKU) – Wells Fargo: Equal Weight → Overweight; Price Target: $38 → $48
  3. CCC Intelligent Solutions (CCCS) – Morgan Stanley: Equal-Weight → Overweight; Price Target: $14 → $15
  4. Cummins (CMI) – Evercore ISI: In-line → Outperform; Price Target: $294 → $408
  5. Equity Residential (EQR) – Stifel: Hold → Buy; Price Target: $77.75 → $81.5
  6. 3M (MMM) – UBS: Neutral → Buy; Price Target: $184
  7. On (ONON) – BTIG Research: Neutral → Buy; Price Target: $64
  8. PACCAR (PCAR) – Evercore ISI: In-line → Outperform; Price Target: $99 → $129
  9. Phillips Edison & Company (PECO) – Wolfe Research: Peer Perform → Outperform; Price Target: $44
  10. Timken (TKR) – Evercore ISI: In-line → Outperform; Price Target: $87 → $91
  11. Carrier Global (CARR) – UBS: Neutral → Buy; Price Target: $94
  12. Viant Technology (DSP) – Canaccord Genuity: Hold → Buy; Price Target: $13 → $18
  13. Bristol-Myers (BMY) – Daiwa Securities: Neutral → Outperform

Downgrades:

  1. Angi Inc. (ANGI) – Citigroup: Buy → Neutral; Price Target: $3.25 → $2
  2. Angi Inc. (ANGI) – Goldman Sachs: Buy → Neutral; Price Target: $3.25 → $2.5
  3. BioAtla (BCAB) – H.C. Wainwright: Buy → Neutral
  4. Caterpillar (CAT) – Evercore ISI: In-line → Underperform; Price Target: $321 → $365
  5. CareCloud (CCLD) – ROTH MKM: Buy → Neutral; Price Target: $5 → $3.5
  6. Coty (COTY) – TD Cowen: Buy → Hold; Price Target: $11 → $8.5
  7. Camden Property (CPT) – Stifel: Buy → Hold; Price Target: $120 → $121
  8. Doximity (DOCS) – Canaccord Genuity: Buy → Hold; Price Target: $40 → $60
  9. ESAB Corp. (ESAB) – Evercore ISI: In-line → Underperform; Price Target: $102 → $122
  10. Eaton (ETN) – Evercore ISI: Outperform → In-line; Price Target: $333 → $389
  11. International Paper (IP) – Exane BNP Paribas: Neutral → Underperform; Price Target: $48.2
  12. Illinois Tool Works (ITW) – Evercore ISI: In-line → Underperform; Price Target: $246 → $255
  13. Republic Bancorp (RBCAA) – Hovde Group: Outperform → Market Perform; Price Target: $78 → $80
  14. Business First Bancshares (BFST) – Hovde Group: Outperform → Market Perform; Price Target: $30 → $31.5
  15. 908 Devices (MASS) – Leerink Partners: Outperform → Market Perform; Price Target: $12 → $4
  16. Progyny (PGNY) – Truist: Buy → Hold; Price Target: $26 → $19
  17. RAPT Therapeutics (RAPT) – Stifel: Buy → Hold; Price Target: $7 → $2
  18. Starbucks (SBUX) – Redburn Atlantic: Neutral → Sell; Price Target: $84 → $77
  19. SoundHound AI (SOUN) – Ladenburg Thalmann: Buy → Neutral; Price Target: $7
  20. Savara (SVRA) – Evercore ISI: Outperform → In-line; Price Target: $7 → $5
  21. Teekay Tankers (TNK) – BofA Securities: Neutral → Underperform; Price Target: $51 → $46
  22. Advanced Drainage Systems (WMS) – Stephens: Overweight → Equal-Weight; Price Target: $170 → $135
  23. RH (RH) – Exane BNP Paribas: Neutral → Underperform; Price Target: $253
  24. Renasant (RNST) – Hovde Group: Outperform → Market Perform
  25. Orrstown Financial Services (ORRF) – Hovde Group: Outperform → Market Perform
  26. South State (SSB) – Hovde Group: Outperform → Market Perform
  27. Alta Equipment Group (ALTG) – Northland Capital: Outperform → Market Perform; Price Target: $20
  28. Arch Resources (ARCH) – Jefferies: Buy → Hold

Coverage Initiated:

  1. Airship AI Holdings (AISP) – The Benchmark Company: Buy; Price Target: $6
  2. Atlanticus (ATLC) – Stephens: Overweight; Price Target: $54
  3. Axalta Coating Systems (AXTA) – Evercore ISI: Outperform; Price Target: $47
  4. Credit Acceptance Corp. (CACC) – Stephens: Equal-Weight; Price Target: $452
  5. America’s Car-Mart (CRMT) – Stephens: Equal-Weight; Price Target: $50
  6. Commvault Systems (CVLT) – Oppenheimer: Outperform; Price Target: $200
  7. Dover (DOV) – UBS: Neutral; Price Target: $217
  8. Emerson (EMR) – Exane BNP Paribas: Outperform; Price Target: $155
  9. Enova International (ENVA) – Stephens: Overweight; Price Target: $108
  10. EZCORP (EZPW) – Stephens: Equal-Weight; Price Target: $13
  11. FirstCash (FCFS) – Stephens: Overweight; Price Target: $137
  12. Fortive (FTV) – UBS: Neutral; Price Target: $84
  13. Jumia (JMIA) – RBC Capital Markets: Sector Perform; Price Target: $5
  14. Katapult Group (KPLT) – Stephens: Equal-Weight; Price Target: $9
  15. NetApp (NTAP) – Oppenheimer: Perform
  16. Nutanix (NTNX) – Oppenheimer: Outperform; Price Target: $80
  17. OneMain Holdings (OMF) – Stephens: Overweight; Price Target: $62
  18. Parker-Hannifin (PH) – UBS: Buy; Price Target: $842
  19. PROG Holdings (PRG) – Stephens: Overweight; Price Target: $60
  20. Pure Storage (PSTG) – Oppenheimer: Outperform; Price Target: $70
  21. Rubrik (RBRK) – Oppenheimer: Perform
  22. Regional Management (RM) – Stephens: Overweight; Price Target: $38
  23. Rockwell Automation (ROK) – Exane BNP Paribas: Outperform; Price Target: $345
  24. Vertiv (VRT) – UBS: Buy; Price Target: $155
  25. World Acceptance (WRLD) – Stephens: Equal-Weight; Price Target: $10

November 12th:

Upgrades

  1. argenx (ARGX) – Wolfe Research: Peer Perform → Outperform, Price Target: $697
  2. Avidbank Holdings (AVBH) – Janney: Neutral → Buy, Price Target: $26
  3. Buckle (BKE) – UBS: Sell → Neutral, Price Target: $46 (up from $31)
  4. Bristol-Myers (BMY) – Leerink Partners: Market Perform → Outperform, Price Target: $73
  5. C.H. Robinson (CHRW) – Citigroup: Neutral → Buy, Price Target: $127 (up from $110)
  6. Canadian National Railway (CNI) – Citigroup: Neutral → Buy, Price Target: $130 (up from $126)
  7. Carter’s (CRI) – Citigroup: Sell → Neutral, Price Target: $50
  8. International Flavors (IFF) – Morgan Stanley: Equal-Weight → Overweight, Price Target: $110 (down from $111)
  9. iHeartMedia (IHRT) – BofA Securities: Underperform → Neutral, Price Target: $3 (up from $1)
  10. SentinelOne (S) – Deutsche Bank: Hold → Buy, Price Target: $32 (up from $25)
  11. South Atlantic Bancshares (SABK) – Janney: Neutral → Buy, Price Target: $17.25
  12. Twilio (TWLO) – Wells Fargo: Equal Weight → Overweight, Price Target: $120 (up from $80)
  13. Viking Holdings Ltd (VIK) – Morgan Stanley: Equal-Weight → Overweight, Price Target: $49 (up from $37)
  14. BWX Technologies (BWXT) – Alembic Global Advisors: Neutral → Overweight
  15. Veris Residential (VRE) – BofA Securities: Neutral → Buy, Price Target: $23 (up from $20)

Downgrades

  1. Asbury Automotive (ABG) – Seaport Research Partners: Buy → Neutral
  2. Atlas Energy Solutions (AESI) – Barclays: Overweight → Equal Weight, Price Target: $19 (down from $23)
  3. Alnylam Pharmaceuticals (ALNY) – Wolfe Research: Peer Perform → Underperform
  4. AeroVironment (AVAV) – Jefferies: Buy → Hold, Price Target: $240
  5. Sprinklr (CXM) – Wells Fargo: Equal Weight → Underweight, Price Target: $6 (down from $8)
  6. Five9 (FIVN) – Wells Fargo: Overweight → Equal Weight, Price Target: $40 (down from $55)
  7. First Mid-Illinois Bancshares (FMBH) – DA Davidson: Buy → Neutral, Price Target: $47 (up from $44)
  8. GlaxoSmithKline (GSK) – Jefferies: Buy → Hold, Price Target: $39.5 (down from $53)
  9. Horace Mann (HMN) – Keefe Bruyette: Outperform → Market Perform, Price Target: $44 (down from $39)
  10. Hudson Pacific Properties (HPP) – Jefferies: Buy → Hold, Price Target: $5
  11. Knight-Swift (KNX) – Citigroup: Neutral → Sell, Price Target: $56
  12. Okta (OKTA) – Deutsche Bank: Buy → Hold, Price Target: $85 (down from $115)
  13. Phunware (PHUN) – H.C. Wainwright: Buy → Neutral, Price Target: $6 (down from $9)
  14. Ross Stores (ROST) – Citigroup: Buy → Neutral, Price Target: $152 (down from $179)
  15. RXO, Inc. (RXO) – Citigroup: Buy → Neutral
  16. Schneider National (SNDR) – Citigroup: Neutral → Sell, Price Target: $30 (down from $32)
  17. TriCo Bancshares (TCBK) – DA Davidson: Buy → Neutral, Price Target: $53 (down from $50)
  18. Old Dominion (ODFL) – Argus: Buy → Hold
  19. Sun Communities (SUI) – BofA Securities: Neutral → Underperform, Price Target: $114
  20. Home Bancorp (HBCP) – Hovde Group: Outperform → Market Perform, Price Target: $54.5 (up from $53)

Coverage Initiated

  1. Allegro Microsystems (ALGM) – Loop Capital: Buy, Price Target: $30
  2. Altimmune (ALT) – UBS: Buy, Price Target: $26
  3. Cadence Design (CDNS) – Loop Capital: Buy, Price Target: $360
  4. Inventiva (IVA) – UBS: Neutral, Price Target: $3
  5. Monolithic Power (MPWR) – Loop Capital: Hold, Price Target: $660
  6. Marvell (MRVL) – Loop Capital: Hold, Price Target: $95
  7. NVIDIA (NVDA) – Redburn Atlantic: Buy, Price Target: $178
  8. NXP Semiconductor (NXPI) – Loop Capital: Buy, Price Target: $300
  9. ON Semiconductor (ON) – Loop Capital: Buy, Price Target: $95
  10. Qualcomm (QCOM) – Loop Capital: Hold, Price Target: $180
  11. Qorvo (QRVO) – Loop Capital: Hold, Price Target: $73
  12. Rambus (RMBS) – Loop Capital: Buy, Price Target: $70
  13. Sagimet Biosciences (SGMT) – UBS: Buy, Price Target: $12
  14. Synopsys (SNPS) – Loop Capital: Buy, Price Target: $675
  15. Skyworks (SWKS) – Loop Capital: Hold, Price Target: $90
  16. VEON (VEON) – The Benchmark Company: Buy, Price Target: $48
  17. FrontView REIT (FVR) – CapitalOne: Overweight, Price Target: $22

November 11th:

Upgrades:

  1. American Homes 4 Rent (AMH) – Evercore ISI: In-line to Outperform, Price Target: $42 (from $41)
  2. BASF AG (BASFY) – Goldman Sachs: Neutral to Buy
  3. Cboe Global Markets (CBOE) – Deutsche Bank: Hold to Buy, Price Target: $222 (from $212)
  4. Cisco (CSCO) – JP Morgan: Neutral to Overweight, Price Target: $66
  5. EPAM Systems (EPAM) – Scotiabank: Sector Perform to Sector Outperform, Price Target: $275 (from $245)
  6. MeridianLink (MLNK) – UBS: Sell to Neutral, Price Target: $22.50 (from $18)
  7. Mercury (MRCY) – Jefferies: Underperform to Hold, Price Target: $42 (from $30)
  8. NETSTREIT (NTST) – Scotiabank: Sector Perform to Sector Outperform, Price Target: $18 (from $16)
  9. Orion Engineered Carbons (OEC) – JP Morgan: Neutral to Overweight, Price Target: $21 (from $20)
  10. Ouster (OUST) – Cantor Fitzgerald: Neutral to Overweight, Price Target: $10 (from $12)
  11. Pinterest (PINS) – Wedbush: Neutral to Outperform, Price Target: $38
  12. Univ Elec (UEIC) – B. Riley Securities: Neutral to Buy, Price Target: $14 (from $11)
  13. Upstart (UPST) – BTIG Research: Sell to Neutral
  14. Valley National (VLY) – JP Morgan: Neutral to Overweight, Price Target: $11 (from $10.50)
  15. Warner Bros. Discovery (WBD) – Wolfe Research: Underperform to Peer Perform
  16. Winnebago (WGO) – Northcoast: Neutral to Buy, Price Target: $75
  17. Tanger Factory (SKT) – BofA Securities: Neutral to Buy, Price Target: $40 (from $35)
  18. Stantec (STN) – Canaccord Genuity: Hold to Buy
  19. Qualys (QLYS) – Wolfe Research: Underperform to Peer Perform
  20. Akamai Tech (AKAM) – HSBC Securities: Hold to Buy, Price Target: $121
  21. Lucid Group (LCID) – R. F. Lafferty: Hold to Buy, Price Target: $4
  22. Fortinet (FTNT) – HSBC Securities: Hold to Buy, Price Target: $111 (from $83)

Downgrades:

  1. Agilon Health (AGL) – JMP Securities: Mkt Outperform to Mkt Perform
  2. Ardelyx (ARDX) – H.C. Wainwright: Buy to Neutral, Price Target: $5.50 (from $11)
  3. Atmus Filtration Technologies (ATMU) – Wells Fargo: Overweight to Equal Weight, Price Target: $45 (from $42)
  4. Bloomin’ Brands (BLMN) – Raymond James: Outperform to Mkt Perform
  5. Cabot (CBT) – JP Morgan: Neutral to Underweight, Price Target: $105
  6. Celanese (CE) – UBS: Buy to Neutral, Price Target: $97 (from $161)
  7. Celanese (CE) – BMO Capital Markets: Market Perform to Underperform, Price Target: $76 (from $138)
  8. GCM Grosvenor (GCMG) – TD Cowen: Buy to Hold, Price Target: $12.50 (from $13.50)
  9. Immunocore (IMCR) – Mizuho: Outperform to Neutral, Price Target: $38 (from $72)
  10. NOV Inc. (NOV) – Citigroup: Buy to Neutral, Price Target: $18 (from $21)
  11. Nerdy (NRDY) – JP Morgan: Neutral to Underweight
  12. NVR (NVR) – Seaport Research Partners: Buy to Neutral
  13. Osisko Gold Royalties (OR) – TD Cowen: Buy to Hold
  14. ProAssurance (PRA) – Piper Sandler: Overweight to Neutral, Price Target: $18
  15. Smartsheet (SMAR) – Guggenheim: Buy to Neutral
  16. Tidewater (TDW) – Raymond James: Strong Buy to Outperform, Price Target: $102 (from $131)
  17. Teck Resources (TECK) – UBS: Buy to Neutral
  18. Tempus AI (TEM) – Stifel: Buy to Hold, Price Target: $65 (from $45)
  19. Vale S.A. (VALE) – UBS: Buy to Neutral, Price Target: $11.50 (from $14)
  20. WhiteHorse Finance (WHF) – Oppenheimer: Outperform to Perform
  21. Xeris Biopharma (XERS) – Piper Sandler: Overweight to Neutral, Price Target: $3
  22. Arcadium Lithium (ALTM) – Scotiabank: Sector Outperform to Sector Perform, Price Target: $5.85
  23. Merck (MRK) – Daiwa Securities: Buy to Neutral
  24. CNH Industrial (CNH) – Northland Capital: Outperform to Market Perform
  25. Geo Group (GEO) – Noble Capital Markets: Outperform to Market Perform
  26. Pacific Biosciences (PACB) – UBS: Buy to Neutral
  27. RAPT Therapeutics (RAPT) – JP Morgan: Neutral to Underweight
  28. RAPT Therapeutics (RAPT) – Piper Sandler: Overweight to Neutral, Price Target: $2 (from $8)

New Coverage:

  1. GeoVax Labs (GOVX) – Alliance Global Partners: Buy, Price Target: $15
  2. Stellantis (STLA) – Evercore ISI: In-line
  3. TriSalus Life Sciences (TLSI) – ROTH MKM: Buy, Price Target: $11